Amgen Inc. Sells Its Stake in Techne Corp.
- Share via
Amgen Inc. has sold its 5.7% stake in Techne Corp. of Minneapolis.
Amgen, based in Thousand Oaks, sold 1.07 million Techne common shares for $17 each, according to documents filed with the Securities and Exchange Commission. Amgen sold the shares on the open market April 15.
Techne is the parent company for Research and Diagnostic Systems Inc., a specialty manufacturer of biological products.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
